Clinical Trial Update: An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 efficacy study of trabectedin in specific subtypes of metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED